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Abstract
Background:  The Adjusted Clinical Group (ACG) system has been used in measuring an
individual's and a population's morbidities. Although all required inputs for running the ACG system
are readily available, patients' morbidities and their associations to health care utilizations have
been rarely studied in Taiwan. Therefore, the objective of this study was using the ACG system to
quantify morbidities for Taiwanese population and to examine their relationship to ambulatory
utilizations and costs.
Methods: This secondary analysis examined claims data for ambulatory services provided to 2.71
million representative Taiwanese in 2002 and 2003. People were grouped by the ACG system
according to age, gender, and all ambulatory diagnosis codes in a given year. The software collapses
the full set of ACGs into six morbidity categories (Non-users, Healthy, Low-morbidity, Moderate-
, High- and Very-high) termed Resource Utilization Bands (RUBs). Each ACG was assigned a
relative weight (RW), which was calculated as the ratio of mean ambulatory cost for each ACG to
that for the overall. The distribution of morbidities was compared between years 2002 and 2003.
The consistency of the distributions of visits, costs, and RWs of each ACG were examined for a
two-year period. The relationship between people's morbidities and their ambulatory utilizations
and costs was assessed.
Results: Ninety-eight percent of the subjects were correctly assigned to ACGs. Except for non-
users (7.9 ~ 8.3%), most subjects were assigned to ACGs of acute and minor diseases and ACGs
of moderate-to-high-morbid chronic diseases. The distributions of ACG-based morbidities were
highly consistent (r = 0.949, p < 0.001) between 2002 and 2003. The ACG-specific visits (r = 0.955,
p < 0.001), costs (r = 0.966, p < 0.001) and RWs (r = 0.991, p < 0.001) were correlated across
two years. People grouped to the high-morbid ACGs had more visits and costs than those grouped
to the low-morbid ACGs. Forty-six percent of the total ambulatory costs were spent by eighteen
percent of the population, who were grouped to the High- and Very-high-morbidity RUBs.
Conclusion: This study demonstrated the feasibility, validity, and reliability of using the ACG
system to measure morbidities in a Taiwan population and to explain their associations with
ambulatory utilizations and costs for the whole country.
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Background
Taiwan launched its single-payer National Heath Insur-
ance (NHI) program in 1995. The NHI enrollees receive
universal and comprehensive benefit coverage in ambula-
tory and hospitalized care. The ambulatory care includes
primary care, dental care, preventive care, laboratory tests,
diagnostic imaging, and prescription drugs [1]. The ambu-
latory care system of Taiwan consisted of 8,560 clinics and
540 hospital-based outpatient departments in 2003 [2].
Around 97% of clinics and 86% of the hospitals were pri-
vately owned; the remains were government-run [2]. In
contrast with the primary care systems in many European
and North American countries, Taiwan has no list or gate-
keeping system. The NHI offers the insured complete free-
dom of choice among providers. Therefore, patients can
seek ambulatory care at any clinic or hospital outpatient
department, regardless of the severity of their illnesses [1].
The volume of ambulatory visits was very high after
implementing the NHI, with a mean number of annual
visits 14.4 per person [2]. The growing rate in total ambu-
latory cost also exceeded that in total hospitalized care.
For the purpose of cost containment, the NHI completed
its phase-in program of comprehensive global budgeting
for the entire health system in 2002 [3]. The entire budget
was divided to four sub-budgets: hospitals and their out-
patients (65.8%), clinics (21.9%), dental care (7.9%), and
Chinese medicine (4.4%) in 2003. Because 45% of the
hospital budget was allocated for outpatient services,
totally 60% of the budget was used for ambulatory care,
not including those for Chinese medicine [2]. This figure
has aroused public concern about whether ambulatory
expenditures are used in alignment with people's actual
medical needs.
Recent studies found that an individual's medical needs
are correlated with his/her total morbidities rather than
his/her particular disease [4-6]. For this reason, accurate
methods are needed to estimate the morbidity burdens of
specific individuals and populations; otherwise, the pay-
ment may become misaligned with medical needs [7]. In
the 1990s, the Johns Hopkins Adjusted Clinical Groups
(ACGs) system was developed to cluster morbidities into
clinically meaningful categories of medical need based on
the mix of diseases that treated by all providers over a
defined time interval, typically one year [8-10]. The sys-
tem uses all diagnostic codes from claims data to quantify
morbidities for individuals and, when aggregates, for
overall population [9,10]. The validity and reliability of
the ACG system has been documented in the United
States [9-11], Canada [7,12], Sweden [13-15], and Spain
[16-18]. Nevertheless, the scales of these studies were
often restricted by the health care systems or the compre-
hensiveness of data. So far, no ACG analysis has been con-
ducted for a whole country.
All ambulatory cares in Taiwan are claimed and uploaded
electronically to the NHI's data warehouse on a monthly
basis. Theoretically, the Taiwan NHI should be the ideal
setting for adopting the ACG system for the whole country
because all required inputs for running the system are
readily available. Although the Department of Health
(DOH), Taiwan, has used the data to estimate disease
prevalence rates [2], no study has measured morbidities
for the entire population yet. Moreover, the association
between population's morbidities and their utilizations
has been rarely discussed [19-21]. By taking advantage of
the comprehensive claims data, the objective of this study
was using the ACG system to quantify morbidities for Tai-
wanese population and to examine their relationship to
ambulatory utilizations and costs.
Methods
Study design and data retrieval
This retrospective study analyzed secondary data of Tai-
wanese population continuously enrolled in the NHI sys-
tem between January 1, 2002 and December 31, 2003.
The data set was issued by the Taiwan National Health
Research Institute (NHRI) for research purposes. The data-
base provides complete individual-level data for age, gen-
der, diagnosis codes (ICD-9-CM), and expenditure for
each ambulatory claim. In addition to primary care, pre-
ventive cares, neonatal and child vaccination shots, prena-
tal screenings, laboratory and radiological studies were all
included as long as they were claimed with definite or pro-
visional diagnoses. For the sake of privacy and confidenti-
ality, all personal identifiers were encrypted before
releasing the data. The application of the data sets was
reviewed and approved by the NHRI.
The original databases consisted of 320 million claims for
22.6 million NHI enrollees. Because the volume of data
exceeded the capability of the software, NHI enrollees
were randomly sampled by selecting those whose birth
date ended with "0" (e.g., 10, 20 or 30). An individual-
specific analytic file was constructed by retrieving and
aggregating data for age, gender, all diagnosis codes, visits
and expenditures reimbursed by the NHI program during
the two 12-month periods in 2002 and 2003, respectively.
ADG and ACG assignment
The ACG software (version 7.0) was used without modify-
ing its grouping algorithm [22]. This algorithm enables
classification of each diagnosis into one of thirty-two clin-
ically cogent morbidity clusters, called Aggregated Diag-
nosis Groups (ADGs) according to the likely persistence
of medical conditions, grade of severity, etiology, diagnos-
tic certainty, and need for specialty care [22]. For each
individual, the total number of unique ADGs, age and
gender were used to group each case into one mutually-
exclusive morbidity cluster, named ACG.BMC Health Services Research 2008, 8:153 http://www.biomedcentral.com/1472-6963/8/153
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ACG-specific visits, ambulatory costs and relative weights
Annual ambulatory cost was defined as the sum of the
total ambulatory utilizations reimbursed by the NHI and
the copayment paid by the individual for a given year.
Mean ambulatory cost for each ACG was calculated by
summing up the costs for the entire population assigned
to a given ACG and then dividing that amount by the
number of people in that ACG. People whose costs
exceeded the 99th percentile within each ACG were trun-
cated to minimize the influence of outliers on mean cost
and to parallel previous validation studies [7,23]. The
same method was used to calculate the mean number of
visits for each ACG in 2002 and 2003. All visits and costs
for preventive care were included and analyzed in this
study.
Each ACG was assigned a relative weight (RW), which was
calculated as the ratio of mean ambulatory cost for each
ACG to the mean ambulatory cost for the entire popula-
tion. The ACG-specific RW was defined as a proxy param-
eter of relative resource use of the given ACG to the
population mean. The RWs for 2002 and 2003 were cal-
culated separately using the data for each year. A person
who was assigned to an ACG with higher RW was
regarded as having relatively higher morbidity burdens
and more medical needs than the general population
[9,10].
Morbidity groups
The ACG system automatically collapsed the full set of
ACG categories into six simplified morbidity categories
(Non-users, Healthy-users, Low, Moderate, High, and
Very-high) termed Resource Utilization Bands (RUBs).
The ambulatory utilizations of each RUB were represented
by the mean number of visits and mean cost of people
assigned to that RUB. The mean morbidity burdens of
each RUB were represented by the mean number of
unique ADGs and mean RW of the people grouped in that
RUB.
Statistical analysis
The technical feasibility of running the ACG system on a
Taiwan population was judged by the percentage of peo-
ple who could be correctly assigned to ACGs. The quality
of the claims data required for running the ACG system
was evaluated by the percentage of non-grouped diagno-
sis codes [22]. Population morbidities were described and
compared according to their assigned ADGs and ACGs
between 2002 and 2003 using the Pearson's correlation
method. Disease markers that were produced by the ACG
system were compared to the disease registries released by
the DOH [2]. Fifteen diseases that were prevalent in Tai-
wanese population and with the same working definition
in both systems were selected for comparison (see Table
2). The association of ACG-specific visits, costs, and RWs
between 2002 and 2003 was also examined by Pearson's
correlation method. The relationships between the mor-
bidities of a population and their ambulatory visits and
costs were assessed. All costs were calculated in New Tai-
wan Dollars (NTD). The exchange rate for U.S. dollars
(USD) to NTD was 34.5 in 2002 and 34.4 in 2003. All
data were analyzed using STATA Version 8 (Stata Corp.,
College Park, TX, USA); p values were 2-sided, with the
significance level set at 0.05.
Results
Morbidity patterns of Taiwanese population
Claims data for 2,709,124 NHI enrollees were retrieved
for analysis (49.3% male; mean age 36.6 ± 20.1 years in
2002 and 36.9 ± 20.0 years in 2003). The quality of diag-
nostic coding was significantly better in 2003 than in
2002 according to the percentage of non-grouped diag-
nosed codes (1.6% vs. 2.0%, p = 0.023).
The study population had parallel ADG distributions
between 2002 and 2003 (r = 0.99, p < 0.001) (Table 1).
Thirty-four percent of the population had one to three
unique ADGs, 46% had four to nine ADGs, and 10% had
ten or more ADGs with an average of 5.0 unique ADGs per
person in 2002 and 5.2 ADGs in 2003 (p < 0.05). The
most frequently assigned ADG was "Time-limited: Minor-
Primary infections" (ADG 2 – 79%) followed by "ADG 1:
Time limited: minor" (39.8%), "ADG 34: Dental"
(36.5%), "ADG 7: Likely to recur: discrete" (35.4%),
"ADG 10: Chronic medical: stable" (32.3%), and "ADG
26: Signs/Symptoms: minor" (31.6%).
Table 2 lists the prevalence rates of fifteen disease markers
produced by the ACG system and recorded on the official
disease registries. The prevalence rates of acute illnesses
were very similar between two resources, such as cataract,
arrhythmia, cerebrovascular diseases, otitis media, and
Parkinson diseases. Higher estimates by the ACG system
than the disease registries were noted in some chronic ill-
nesses like diabetes, hypertension, tuberculosis, hepatitis,
and urinary tract stones.
Ninety-eight percent of the population could be appropri-
ately classified into eighty-two ACGs [see Additional file
1]. The percentage of non-users (i.e., ACG 5200) was 8.3%
in 2002 and 7.9% in 2003. The population distribution
for ACGs was highly consistent between 2002 and 2003 (r
= 0.949, p < 0.001), but people were not equally distrib-
uted among ACGs. Fifty percent of the population was
assigned to eleven ACGs, and 67% of the population was
assigned to twenty ACGs. Most assigned ACGs were
divided between the following two morbidity groups:
people with acute and minor diseases such as ACG 0300,
2400, 1800, 2100 and 3400, and those with moderate- toBMC Health Services Research 2008, 8:153 http://www.biomedcentral.com/1472-6963/8/153
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high-morbid chronic diseases such as ACG 4910, 4920
and 5050.
ACG-specific visits, costs and RWs
The statistics of mean visit, cost, and RW of each ACG in
2002 and 2003 are listed in the Additional file 1. The
ACG-specific visits (r = 0.955, p < 0.001), costs (r = 0.966,
p < 0.001) and RWs (r = 0.991, p < 0.001) were highly con-
sistent between two years. Ninety-two percent of the pop-
ulation had at least one ambulatory encounter with an
average 15.3 ± 14.2 visits and NTD 11,488 ± 52,917 cost
in 2002; and 14.9 ± 13.9 visits and NTD 12,017 ± 35,495
cost in 2003. The ACG 5070 had the highest RW (5.691 in
2002; 6.023 in 2003) while ACG 1600 had the lowest RW
(0.065 in 2002; 0.046 in 2003).
Cost related to morbidities
The mean number of visits and costs of the people
assigned to a given ACG was associated with its morbidity
burdens. People assigned to ACGs with chronic, recurrent,
unstable medical conditions or more ADG combinations
required more costly care than those with acute, stable
conditions or fewer ADG combinations [see Additional
file 1]. Table 3 lists the population distributions and
ambulatory utilizations among RUBs. In 2002, thirty-four
percent of the population was classified as Healthy-users
and Low-morbidity RUBs and they used 18.4% of total
visits and 11.6% of total costs. Conversely, eighteen per-
cent of the population was grouped as High- and Very-
high-morbidity RUBs, but they used 37.2% of total visits
and 46.3% of total costs.
Discussion
This study demonstrated the feasibility of using the ACG
case-mix adjustment system to quantify a large popula-
tion's morbidities in Taiwan. The administrative barriers
to running the system are low because that all required
inputs are routinely collected. The coding quality is
Table 1: Taiwanese morbidity patterns by ADG in 2002 and 2003
ADG & Description
Year 2002 Year 2003
N% N%
1 Time Limited: Minor 1,006,048 39.8 1,019,484 40.4
2 Time Limited: Minor-Primary Infections 1,992,226 78.9 1,968,976 78.0
3 Time Limited: Major 235,366 9.3 237,030 9.4
4 Time Limited: Major-Primary Infections 449,075 17.8 445,353 17.6
5 Allergies 302,123 12.0 315,368 12.5
6 Asthma 87,299 3.5 82,509 3.3
7 Likely to Recur: Discrete 895,045 35.4 933,523 37.0
8 Likely to Recur: Discrete-Infections 564,424 22.4 551,992 21.9
9 Likely to Recur: Progressive 60,111 2.4 61,405 2.4
10 Chronic Medical: Stable 815,730 32.3 859,344 34.1
11 Chronic Medical: Unstable 470,946 18.7 476,131 18.9
12 Chronic Specialty: Stable-Orthopedic 108,891 4.3 112,290 4.4
13 Chronic Specialty: Stable-Ear, Nose, Throat 40,914 1.6 43,052 1.7
14 Chronic Specialty: Stable-Eye 393,814 15.6 398,962 15.8
16 Chronic Specialty: Unstable-Orthopedic 65,792 2.6 64,459 2.6
17 Chronic Specialty: Unstable-Ear, Nose, Throat 31,632 1.3 32,406 1.3
18 Chronic Specialty: Unstable-Eye 91,887 3.6 99,621 3.9
20 Dermatologic 312,630 12.4 315,398 12.5
21 Injuries/Adverse Effects: Minor 514,994 20.4 590,592 23.4
22 Injuries/Adverse Effects: Major 397,795 15.8 393,998 15.6
23 Psychosocial: Time Limited, Minor 23,037 0.9 22,938 0.9
24 Psychosocial: Recurrent or Persistent, Stable 189,041 7.5 187,296 7.4
25 Psychosocial: Recurrent or Persistent, Unstable 35,821 1.4 36,799 1.5
26 Signs/Symptoms: Minor 799,092 31.6 854,014 33.8
27 Signs/Symptoms: Uncertain 689,129 27.3 714,919 28.3
28 Signs/Symptoms: Major 421,569 16.7 431,382 17.1
29 Discretionary 199,908 7.9 195,420 7.7
30 See and Reassure 76,531 3.0 81,357 3.2
31 Prevention/Administrative 454,848 18.0 479,046 19.0
32 Malignancy 40,496 1.6 40,945 1.6
33 Pregnancy 51,640 2.0 48,975 1.9
34 Dental 930,053 36.8 930,816 36.9BMC Health Services Research 2008, 8:153 http://www.biomedcentral.com/1472-6963/8/153
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acceptable given that the percentage of non-grouped diag-
noses codes was lower than the 5% standard [22]. Moreo-
ver, the reliability of the system on Taiwanese population
is documented because that the distributions of ADGs,
ACGs, and RWs were quite consistent across the two years
studied. Finally, the system was validated by the finding
that higher ambulatory costs are associated with the accu-
mulation and severity of morbidity burdens. Although the
validity and reliability of the system on Taiwanese has
been verified in two small-scale studies [20,21], this study
highlights that the ACG system works very well for large
datasets.
In contrast with previous ACG studies, the findings of this
study are more significant for the following reasons. First,
the scale of this analysis was larger than that of other stud-
ies conducted in the United States [9,10], Canada [7,12],
Sweden [13,14], and Spain [17,18]. Second, previous
large-scale studies have often been limited to specific pop-
ulation [14,18,24], health care programs [9,10], or geo-
graphic areas [7,12]. This study quantified, for the first
time, morbidities on a national basis. The findings of this
study are representative and can be benchmark informa-
tion for further studies and applications. Third, this study
might be one of the first ACG analyses conducted in Asia,
where the health care behavior, culture, delivery systems,
Table 2: Comparison of disease prevalence rates by ACG and Department of Health (DOH), Taiwan
Disease markers
Prevalence rate (per 1,000 NHI enrollees)
DOH ACG
Asthma 34.4 33.6
Benign prostate hypertrophy 15.0 15.6
Cataract 28.7 29.8
Chronic obstructive pulmonary diseases 38.0 36.0
Cardiac arrhythmia 18.5 18.6
Cerebrovascular diseases 21.1 21.5
Diabetes 44.4 50.0
Hepatitis 49.2 54.0
Hypertension 91.7 110.2
Malignant tumors 15.0 16.1
Otitis media 31.5 30.1
Parkinson diseases 2.78 3.00
Pulmonary tuberculosis 5.8 7.5
Complications in pregnancy, childbirth, and puerperium 20.0 19.1
Urinary tract stones 15.1 18.1
Table 3: Utilizations and costs among resource utilization bands (RUBs) in 2002 and 2003.
RUBs Population 
distribution (%)
Average number
of ADGs
Relative 
weights
Average visit 
(% of total visits)
Average cost in NTD 
(% of total costs)
Year 2002
Non-users 8.3 0 0 0 0
Healthy users 10.0 1.4 0.15 4.9 (3.5) 1,806 (1.7)
Low-morbidity 23.8 2.9 0.39 8.8 (14.9) 4,362 (9.9)
Moderate 39.6 5.5 1.00 15.8 (44.4) 11,197 (42.1)
High 14.2 8.9 1.98 25.9 (26.1) 22,134 (29.8)
Very-high 4.1 11.7 3.83 38.6 (11.1) 42,762 (16.5)
Year 2003
Non-users 7.9 0 0 0 0
Healthy users 8.0 1.4 0.13 4.0 (2.3) 1,490 (1.1)
Low-morbidity 25.3 2.8 0.35 7.8 (14.5) 4,049 (9.3)
Moderate 40.4 5.5 0.99 14.8 (44.4) 11,252 (41.5)
High 14.3 8.9 2.01 25.6 (27.1) 23,468 (30.7)
Very-high 4.1 11.7 3.99 38.6 (11.1) 46,575 (17.4)BMC Health Services Research 2008, 8:153 http://www.biomedcentral.com/1472-6963/8/153
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and health insurance systems were different to the Euro-
pean and North American countries. The study findings
underline the robustness of the ACG system across these
barriers.
The observed ACG-based morbidities for Taiwanese
revealed several notable characteristics. First, the mean
number of unique ADGs per person (5.0 to 5.2) was
higher than that reported in Canada [7], Spain [18], and
the United States [9,22]. Second, Taiwanese population
had higher incidence of cases in almost all ADG categories
than people in Canada [7], Sweden [14], Spain [18], and
the United States [22]. No evidence from this or previous
studies can support or reject the hypothesis that Taiwan-
ese are less healthy than people of the other countries.
However, because the ACG system is mainly based on
NHI claims, several influential factors to the high morbid-
ity burdens should be considered. First of all, the NHI pro-
vides broad ambulatory coverage and all of them are
grouped by the ACG system. For instance, newborns and
children receive physical checkup and scheduled vaccina-
tions at clinics or hospitals, and thus the number of visits
for ACG0100 and ACG0200 are quite high. For patients
with chronic illnesses, they need to refill prescription
drugs at ambulatory settings every one to three months.
Another concern is the NHI's low cost sharing policy and
people's moral hazard. In 2003, the mean annual medical
cost was USD 824 for Taiwanese, which was lower than
the figure of many European countries such as France
(USD 3,145), Germany (USD 3,183), Italy (USD 2,179),
and United Kingdoms (USD 2,392) [2]. The average cost
per visit was USD 23.8 in 2003 and patients paid about
8.89% of this regardless of their utilization rates [1,20].
The de facto absence of a referral system and low copay-
ment deters people from using the resources cautiously.
Finally, the NHI's payment schemes to doctors also
increased the likelihoods of high consultation rates. There
were 32,390 western medicine doctors in 2003, about
14.3 doctors per 10,000 people [2]. One-third of these
doctors work as general practitioners at clinics and they
are paid entirely on a fee-for-service basis. On the other
hand, most of the specialists practicing in hospitals are
paid on a salary basis plus volume-based bonus benefits.
Therefore, there are financial incentives for doctors to
increase service volumes for all kinds of ambulatory care
[1].
The third finding was the disproportional concentration
of ambulatory resources to the high-morbidity popula-
tion. The top 4% of the NHI population grouped into the
Very-high-morbidity RUB had nine times more visits and
thirty times higher costs than people grouped into the
Healthy-users RUB. These high-morbidity populations
often had more than one chronic illness and multiple co-
morbidities, which combined to produce a complex and
challenging clinical dynamic [25]. This finding was con-
sistent with recent reports by Starfield et al. that health
care needs correlate with total morbidity burdens rather
than particular diseases [5,6].
It is worth noting that the healthy users and low-morbid-
ity population also used considerable ambulatory
resources in Taiwan. This finding was consistent with the
statistics released by the DOH that a high percentage of
the ambulatory resources were used in the treatment of
symptoms or minor illnesses [2]. This figure raises a sig-
nificant concern that whether ambulatory resources are
used in alignment with population's medical needs, espe-
cially after implementing the global budget payment
scheme. Given the limited budget, the utilization and cost
by the healthy-users and low-morbidity population will
inevitably decrease the budget for the high-morbidity
patients. Moreover, physician fee paid by the NHI is same
for all ambulatory consultations, regardless of patient's
morbidities. There are incentives for doctors to treat low-
morbidity patients. Additionally, the cost for outpatient
services is generally lower than that of the inpatient care.
For hospitals run by caped revenue budgets, there are also
financial incentives to increase outpatient services and
decrease inpatient capacities. Therefore, the NHI program
is potentially threatened by steering resources away from
the high-morbidity population if a growing share of the
budget is used for the low-morbidity population. In fact,
the NHI has noticed this issue and adopted several strate-
gies. For instance, the NHI adopted the upper volume
threshold policy for clinics and outpatient services in Jan-
uary 2001 [1]. The physician fees for ambulatory care are
discounted above the pre-set volume limit. Furthermore,
many over-the-counter drugs have been no longer reim-
bursed since 2004. After long-term negotiation with the
legislature and health care providers, the NHI has
increased patient's cost sharing for hospital outpatient
services since July 2006.
Study limitations
Some limitations of this study should be mentioned. First,
although the quality of coding and the non-grouped diag-
nosis rate in this study was within an acceptable range, the
accuracy of diagnoses has not been systematically esti-
mated. Therefore, the validity of the ACG system is still
subject to coding quality. In fact, the ACG system is rela-
tively resistant to the inaccuracy of diagnosis because the
exact diagnostic code is not of prime interest in the ACG
system [26]. The point is that it belongs to the right cluster
of diagnoses in terms of ADGs, resulting in the expression
of each patient's health status as a combination of differ-
ent types of morbidity [14]. Inaccuracy regarding a
patient's registered health condition might have occurred
only if very different diagnoses are assigned to different
types of morbidity [17]. Second, physicians may assignBMC Health Services Research 2008, 8:153 http://www.biomedcentral.com/1472-6963/8/153
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provisional diagnoses during initial visits. This is particu-
larly significant for patients with diseases that required
bacteriological, biochemical, or radiological studies when
making a diagnosis. For instance, the estimated preva-
lence rates of diabetes, hepatitis, and pulmonary tubercu-
losis by ACG system were higher than the official statistics.
Orueta et al. have used "episode of care" as the morbidity
observation unit which could offer a longitudinal view of
health problems and decrease the effects of provisional
diagnoses [17]. Third, previous studies showed that
explanatory abilities of the ACG-based morbidities were
quite good for the same-year and next-year ambulatory
visits and costs but not as good for inpatient costs in Tai-
wan [20,21]. Therefore, this analysis was designed mainly
based on ambulatory claims and the findings could not be
generalized to inpatient settings.
Policy implications
The influence of morbidities on medical needs has sel-
dom been addressed in Taiwan. Although the DOH con-
tinuously monitors the prevalence of diseases,
epidemiological statistics focus more on illnesses rather
than on morbidities. Given the association between mor-
bidities and ambulatory utilization and cost, many health
care insurance programs in the United States have
adopted the ACG system to assess the case mix of enroll-
ees, estimate morbidities, adjust capitation rates [27,28],
identify high-cost patients [29], and predict resource utili-
zation accordingly [30]. The ACG system has also been
adopted in Canada and several European countries to
improve the efficiency and quality of medical care [12-
17].
Although the accuracy and quality of diagnostic coding
needs continuous monitoring and improvement, this
study suggests that the health care authorities, the NHI,
and policy makers can take advantage of nationwide,
comprehensive and readily available datasets to regularly
measure an individual's and a population's morbidities in
Taiwan. Together with the findings in previous studies
[20,21], the morbidity information can be considered by
policy makers when budgeting and allocating ambulatory
resources. Further, the ACG system can help providers to
identify the high-morbidity groups likely to cost more
than the population mean. These high-morbidity popula-
tions merit organized ambulatory services such as case
management programs to improve their health care qual-
ity and, at the same time, decrease costs.
Conclusion
By routinely collecting administrative data, the ACG sys-
tem provides a potentially useful measure of morbidities
within a population. This study demonstrated the feasibil-
ity, validity, and reliability of using the ACG system to
measure morbidities in a Taiwan population and to
explain their associations with ambulatory utilizations
and costs for the whole country.
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